Sangita M. Baxi

Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity

Timothy S. Fisher, Cris Kamperschroer, Theodore Oliphant et al. · Cancer Immunology Immunotherapy · 2012 · 162 citations · Full text

Tumor Biology, Cancer Immunosurveillance, T-regulatory Cell +7

Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses

Weston R. Gould, Sangita M. Baxi, Richard L. Schroeder et al. · Journal of Thrombosis and Haemostasis · 2005 · 118 citations

Inflammation, Thrombosis, Thrombopoiesis +13

miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells

Rounak Nassirpour, Pramod P. Mehta, Sangita M. Baxi et al. · PLoS ONE · 2013 · 93 citations · Full text

Breast Oncology, Cell Death, Mir-221 Promotes Tumorigenesis +17

Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design

Hengmiao Cheng, Chunze Li, Simon Bailey et al. · ACS Medicinal Chemistry Letters · 2012 · 78 citations · Full text

Drug Target, Pharmaceutical Chemistry, Empirical Scaling Tool +18

Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90

Pramod P. Mehta, Pamela Whalen, Sangita M. Baxi et al. · Clinical Cancer Research · 2011 · 34 citations